Notes to the Consolidated Financial Statements continued 28.
Share-based Payments During the year, the Company operated the Unapproved Share Option Scheme, the Approved Share Option Scheme, the Long Term Incentive Plan and the Save As You Earn SAYE Share Option Scheme as described below: Unapproved and Approved Share Option Schemes Under these Schemes, options are granted to certain Executives and employees of the Group excluding Executive Directors to purchase shares in the Company at a price fixed at the average market value over the three days prior to the date of grant.
For the options to vest, there must be an increase in earnings per share of at least 12% above the growth in the UK Retail Prices Index RPI over a three year period.
Once vested, options must be exercised within ten years of the date of grant.
Long Term Incentive Plan 2008 Vesting is dependent on two performance conditions which must be satisfied over a three year performance period commencing from the start of the financial year within which the award is granted.
50% of the award will vest dependent on the Companys TSR performance against an appropriate comparator group.
50% of the award will vest subject to a performance condition based on annual earnings per share targets.
Each of the TSR and EPS elements is subject to an additional ROCE underpin.
Unless the Companys ROCE is 10% or more in the final year of the performance period, the award will lapse in full.
SAYE Option Scheme This scheme is open to all UK employees.
Participants save a fixed amount of up to 500 per month for either three or five years and are then able to use these savings to buy shares in the Company at a price fixed at a 20% discount to the market value at the start of the savings period.
Prior to 16 October 2012, participants were able to save for a seven year period.
The SAYE options must ordinarily be exercised within six months of the completion of the relevant savings period.
The exercise of these options is not subject to any performance criteria.
Long Term Incentive Plan 2017 a Long Term Incentive Plan Awards Vesting is dependent on three performance conditions which must be satisfied over a three year performance period commencing from the start of the financial year within which the award is granted.
One third of each award is subject to a performance condition based on the Companys TSR performance over the performance period relative to an appropriate comparator over the performance period.
Two thirds of each award is subject to a performance condition based on the growth in the Groups underlying diluted EPS over the performance period.
Both the TSR element and the EPS element are subject to an additional ROCE performance measure.
Unless the Groups ROCE is 10% or more in the final year of the performance period, the awards will lapse in full regardless of TSR and EPS performance.
For the purposes of this note they are detailed under the heading Long Term Incentive Plan.
b Qualifying LTIP Awards In addition, awards can be structured as Qualifying LTIP Awards, consisting of a Company Share Option Plan CSOP option and a nil-cost LTIP award, with the ordinary award scaled back at exercise to take account of any gain made on exercise of the CSOP option.
The Qualifying LTIP Awards are granted to UK Senior Executive Team which includes the UK resident Executive Directors.
The performance conditions are the same as those attached to the awards granted under Approved Share Option Schemes and Long Term Incentives Plan 2017.
For the purposes of this note they are detailed under the heading Long Term Incentive Plan Qualifying LTIP Awards.
c Market Value Options Market value options may be granted under the LTIP 2017 as tax-advantaged CSOP options and as Unapproved share options.
These options are granted to certain Executives and employees of the Group excluding Executive Directors to purchase shares in the Company at a price fixed at the average market value over the three days prior to the date of grant.
For the purposes of this note they are detailed under the headings Unapproved and Approved Share Option Schemes.
148 Dechra Pharmaceuticals PLC Annual Report and Accounts for the year ended 30 June 2018 www.
Total share options exercisable at 30 June 2018 are 56,094.
Stock Code: DPH 149 Notes to the Consolidated Financial Statements continued 28.
Total share options exercisable at 30 June 2017 are 68,707.
The weighted average exercise price of options eligible to be exercised at 30 June 2018 was 596.85p 2017: 470.86p.
For options exercised during the year, the weighted average market price at the date of exercise was 2,142.35p 2017: 1,415p.
The weighted average remaining contractual lives of options outstanding at the Consolidated Statement of Financial Position date was 3.8 years 2017: 3.3 years.
Outstanding options on all Long Term Incentive Plan, Approved and Unapproved plans prior to 30 June 2017 were exercisable at 30 June 2018.
No options issued under SAYE plans were exercisable at 30 June 2018 2017: nil.
150 Dechra Pharmaceuticals PLC Annual Report and Accounts for the year ended 30 June 2018 www.
Share-based Payments continued The fair values for shares granted under the Unapproved, Approved and SAYE Option Schemes have been calculated using the BlackScholes option pricing model.
The fair values of shares awarded under the Long Term Incentive Plan have been calculated using a Monte Carlo simulation model which takes into account the market-based performance conditions attaching to those shares.
The assumptions used in calculating fair value are as follows: Long Term Incentive Plan Date of grant 07 03 17 07 03 17 10 10 16 19 09 16 22 03 16 15 09 15 Number of shares awarded 21,033 21,033 5,319 149,463 8,786 220,621 Share price at date of grant 1652p 1652p 1389p 1379p 1200p 990p Exercise price Nil Nil Nil Nil Nil Nil Expected life 2 years 1 year 3 years 3 years 3 years 3 years Risk-free rate 0.12% 0.12% 0.12% 0.12% 0.46% 0.68% Volatility 22% 22% 22% 22% 22% 22% Dividend yield 1.54% 1.54% 1.54% 1.54% 1.61% 0.54% Fair value per share 1500p 1500p 1108p 1108p 1021p 764p Unapproved and Approved Share Option Schemes Date of grant 19 09 16 18 03 16 15 09 15 Number of shares awarded 106,000 6,000 74,000 Share price at date of grant 1379p 1185p 990p Exercise price 1369p 1188p 975p Expected life 6.5 years 6.5 years 6.5 years Risk-free rate 0.47% 1.02% 1.47% Volatility 26% 26% 27% Dividend yield 1.54% 1.62% 0.54% Fair value per share 305p 273p 284p Long Term Incentive Plan 2017 Valuation date 02 03 18 Award date 02 03 18 Vesting date 30 09 20 Expected exercise 30 09 20 Nil-cost options Nil-cost options Conditional CSOP linked and Market value Type of awards CSOP linked share awards standalone options options Holding period restriction 2 years 2 years N A N A Number of awards at grant 20,459 40,918 4,033 8,066 9,682 19,363 114,113 Share price at date of grant 2506p 2506p 2506p 2506p 2506p 2506p 2506p Exercise price Nil Nil Nil Nil Nil Nil Nil Expected life years years years years years years years Risk-free rate 0.82% 0.82% 0.82% 0.82% 0.82% 0.82% 1.20% Volatility 23.21% 23.21% 23.21% 23.21% 23.21% 23.21% 23.21% Dividend yield 1.91% 1.91% 1.91% 1.91% 1.91% 1.91% 1.91% Fair value per share 1979p 22.50p 19.79p 22.50p 21.33p 24.25p 522p Stock Code: DPH 151
